Sanofi advances amlitelimab toward global filings after phase 3 results in atopic dermatitis

Trevi Therapeutics reports key Phase 2b CORAL trial results for oral nalbuphine ER

Hansa Biopharma receives 2025 SwedenBIO Award

Mabwell reports first patient dosed with 7MW4911 in US trial

Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025

Actuate Therapeutics advances elraglusib tablet into Phase 1/2 trial for refractory cancers

EU approves DAWNZERA for hereditary angioedema

Charles River collaborates with Gazi University on rare disease gene therapy research

Avacta secures FDA clearance for second pre|CISION oncology programme

LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus

Syngene International and Bristol Myers Squibb extend collaboration to 2035

Rakuten Medical expands academic access to IR700 dye

Insilico Medicine signs co-development collaboration agreement with Hygtia Therapeutics

HistoIndex partners Houston Research Institute

GSK agrees to acquire RAPT Therapeutics to strengthen food allergy pipeline